Tricking an ancient immune function to eradicate hepatocellular carcinoma

The circulating apoptosis inhibitor of macrophage (AIM) protein performs differential preventive roles against liver steatosis and hepatocellular carcinoma (HCC) development. Since non-alcoholic fatty liver disease, which is known as a manifestation of metabolic syndrome, has been increasingly highl...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyazaki, Toru, Arai, Satoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Author's Views
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905303/
https://www.ncbi.nlm.nih.gov/pubmed/27308467
http://dx.doi.org/10.4161/23723556.2014.985915
_version_ 1782437243712962560
author Miyazaki, Toru
Arai, Satoko
author_facet Miyazaki, Toru
Arai, Satoko
author_sort Miyazaki, Toru
collection PubMed
description The circulating apoptosis inhibitor of macrophage (AIM) protein performs differential preventive roles against liver steatosis and hepatocellular carcinoma (HCC) development. Since non-alcoholic fatty liver disease, which is known as a manifestation of metabolic syndrome, has been increasingly highlighted for its association with HCC, therapeutic application of AIM would open the door toward a new mode of treatment for modern hepatic diseases.
format Online
Article
Text
id pubmed-4905303
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-49053032016-06-15 Tricking an ancient immune function to eradicate hepatocellular carcinoma Miyazaki, Toru Arai, Satoko Mol Cell Oncol Author's Views The circulating apoptosis inhibitor of macrophage (AIM) protein performs differential preventive roles against liver steatosis and hepatocellular carcinoma (HCC) development. Since non-alcoholic fatty liver disease, which is known as a manifestation of metabolic syndrome, has been increasingly highlighted for its association with HCC, therapeutic application of AIM would open the door toward a new mode of treatment for modern hepatic diseases. Taylor & Francis 2015-01-23 /pmc/articles/PMC4905303/ /pubmed/27308467 http://dx.doi.org/10.4161/23723556.2014.985915 Text en © 2015 The Author(s). Published with license by Taylor & Francis Group, LLC http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted.
spellingShingle Author's Views
Miyazaki, Toru
Arai, Satoko
Tricking an ancient immune function to eradicate hepatocellular carcinoma
title Tricking an ancient immune function to eradicate hepatocellular carcinoma
title_full Tricking an ancient immune function to eradicate hepatocellular carcinoma
title_fullStr Tricking an ancient immune function to eradicate hepatocellular carcinoma
title_full_unstemmed Tricking an ancient immune function to eradicate hepatocellular carcinoma
title_short Tricking an ancient immune function to eradicate hepatocellular carcinoma
title_sort tricking an ancient immune function to eradicate hepatocellular carcinoma
topic Author's Views
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905303/
https://www.ncbi.nlm.nih.gov/pubmed/27308467
http://dx.doi.org/10.4161/23723556.2014.985915
work_keys_str_mv AT miyazakitoru trickinganancientimmunefunctiontoeradicatehepatocellularcarcinoma
AT araisatoko trickinganancientimmunefunctiontoeradicatehepatocellularcarcinoma

Ejemplares similares